Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT00951457 · COMPLETED

Trial details

NCT number: NCT00951457
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2009-03-01
Primary completion: 2012-08-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.